PTC Therapeutics, Inc. Deferred Tax Liabilities, Unrealized Gains on Trading Securities
PTC Therapeutics, Inc. (PTCT) had Deferred Tax Liabilities, Unrealized Gains on Trading Securities of $0 as of 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities · last filed 2019-03-01
- 2018-12-31: Deferred Tax Liabilities, Unrealized Gains on Trading Securities $0.00.
- 2017-12-31: Deferred Tax Liabilities, Unrealized Gains on Trading Securities $140.00K.
- 2016-12-31: Deferred Tax Liabilities, Unrealized Gains on Trading Securities $235.00K.
- 2015-12-31: Deferred Tax Liabilities, Unrealized Gains on Trading Securities $0.00.
| Period end | Deferred Tax Liabilities, Unrealized Gains on Trading Securities |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-01 |
| 2017-12-31 | $140.00K 10-K · filed 2019-03-01 |
| 2016-12-31 | $235.00K 10-K · filed 2018-03-06 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |